Corcept Therapeutics | CORT - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Alaunos Therapeutics USD 585K 260K 2025-09
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Ardelyx USD 83.61M 378K 2025-09
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 41.79M 3.84M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Canopy Growth CAD 29.53M 999K 2025-09
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.42M 456K 2025-12
J&J USD 6.75B 831M 2025-12
Knight Therapeutics CAD 31.02M 464K 2025-09
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Merck USD 2.85B 215M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Novartis USD 3.31B 134M 2025-09
Novartis USD 3.3B 137M 2025-09
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.87M 70K 2025-12
Pfizer USD 4.08B 894M 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12